Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Comparison of Two Bronchodilator Inhalers in Adolescents and Adults With Exercise-Induced Asthma
This study has been completed.
Sponsored by: IVAX Research LLC
Information provided by: IVAX Research LLC
ClinicalTrials.gov Identifier: NCT00085774
  Purpose

This study is designed to examine the effectiveness of two bronchodilator inhalers in patients who have exercise- induced asthma


Condition Intervention Phase
Exercise-Induced Asthma
Drug: Bronchodilator
Phase III

MedlinePlus related topics: Asthma Exercise and Physical Fitness
U.S. FDA Resources
Study Type: Interventional
Study Design: Prevention, Randomized, Double-Blind, Placebo Control, Crossover Assignment, Safety/Efficacy Study
Official Title: Single-Dose Effectiveness Comparison of Two Bronchodilator Inhalers in Adolescents and Adults With Exercise-Induced Asthma

Further study details as provided by IVAX Research LLC:

Study Start Date: June 2004
  Eligibility

Ages Eligible for Study:   12 Years to 40 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Demonstrable exercise-induced asthma, with or without asthma (predicted FEV1 70% or higher prior to exercise challenge);
  • No contraindications for exercising maximally

Exclusion Criteria:

  • Continuous requirement for beta-blockers, MAO inhibitors, tricyclic antidepressants, long-acting inhaled beta-agonists, antileukotrienes and/or cromones, steroids other than those inhaled
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00085774

Locations
United States, Colorado
Colorado Allergy and Asthma Centers, PC
Denver, Colorado, United States, 80230
Colorado Allergy and Asthma Centers, PC
Englewood, Colorado, United States, 80112
Colorado Allergy and Asthma Centers, PC
Lakewood, Colorado, United States, 80401
Sponsors and Collaborators
IVAX Research LLC
  More Information

Study ID Numbers: IXR-302-4-167
Study First Received: June 14, 2004
Last Updated: June 23, 2005
ClinicalTrials.gov Identifier: NCT00085774  
Health Authority: United States: Food and Drug Administration

Study placed in the following topic categories:
Asthma, Exercise-Induced
Hypersensitivity
Lung Diseases, Obstructive
Respiratory Tract Diseases
Lung Diseases
Hypersensitivity, Immediate
Asthma
Respiratory Hypersensitivity

Additional relevant MeSH terms:
Immune System Diseases
Bronchial Diseases

ClinicalTrials.gov processed this record on January 16, 2009